Abstract:Diabetic retinopathy (DR) is considered a primarily microvascular complication of diabetes. Müller glia cells are at the centre of the retinal neurovascular unit and play a critical role in DR. We therefore investigated Müller cell-specific signalling pathways that are altered in DR to identify novel targets for gene therapy. Using a multi-omics approach on purified Müller cells from diabetic db/db mice, we found the mRNA and protein expression of the glucocorticoid receptor (GR) to be significantly decreased, while its target gene cluster was down-regulated. Further, oPOSSUM TF analysis and ATAC- sequencing identified the GR as a master regulator of Müller cell response to diabetic conditions. Cortisol not only increased GR phosphorylation. It also induced changes in the expression of known GR target genes in retinal explants. Finally, retinal functionality was improved by AAV-mediated overexpression of GR in Müller cells. Our study demonstrates an important role of the glial GR in DR and implies that therapeutic approaches targeting this signalling pathway should be aimed at increasing GR expression rather than the addition of more ligand.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the changes in specific signal pathways of Müller cells in Diabetic Retinopathy (DR) in order to identify new gene therapy targets. Specifically, the study focused on the role of Glucocorticoid Receptor (GR) in the response of Müller cells under diabetic conditions. Through multi - omics methods, the study found that the expression of GR mRNA and protein in Müller cells in diabetic mouse models decreased significantly, and its target gene clusters were also down - regulated. Further analysis showed that GR is the main regulatory factor for Müller cells in response to diabetic conditions. In addition, the study also explored the possibility of improving retinal function through AAV - mediated GR over - expression, suggesting a new strategy for treating DR by increasing GR expression rather than simply adding more ligands. ### Research Background Diabetic Retinopathy (DR) is one of the major microvascular complications of diabetes, affecting retinal physiology and vision. Müller cells are located at the center of the retinal neurovascular unit and play a key role in the occurrence and development of DR. Therefore, researchers are committed to exploring the specific signal pathways in Müller cells that change in DR to find new gene therapy targets. ### Main Findings 1. **Decreased GR Expression**: - In diabetic mouse models, the expression of GR mRNA and protein in Müller cells decreased significantly. - The target gene clusters of GR also showed down - regulation. 2. **GR as a Main Regulatory Factor**: - Through oPOSSUM transcription factor analysis and ATAC sequencing, it was determined that GR is the main regulatory factor for Müller cells in response to diabetic conditions. - Glucocorticoids not only increased the phosphorylation of GR but also induced changes in the expression of known GR target genes in retinal explants. 3. **AAV - Mediated GR Over - expression**: - Through AAV - mediated over - expression of GR in Müller cells, retinal function was improved. - This finding indicates that treatment methods targeting the GR signal pathway should focus on increasing GR expression rather than simply adding more ligands. ### Conclusion This study revealed the important role of Glucocorticoid Receptor (GR) in Diabetic Retinopathy (DR) and suggested the therapeutic potential of increasing GR expression through gene therapy. This provides an important theoretical basis and experimental evidence for the development of new DR treatment methods.

The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice

Cell-type specific impact of glucocorticoid receptor activation on the developing brain

Müller Glial Expression of REDD1 Is Required for Retinal Neurodegeneration and Visual Dysfunction in Diabetic Mice

Glucocorticoid Receptor Signaling Is Critical for Mouse Corneal Development, Inhibition of Inflammatory Response, and Neovascularization of the Cornea

Müller cells harboring exosomal lncRNA OGRU modulates microglia polarization in diabetic retinopathy via serving as miRNA sponges

Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose Fluctuations

Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy

IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy

Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Müller cell ablation

The role of retinal Müller cells in diabetic retinopathy and related therapeutic advances

GLCCI1 alleviates GRP78-initiated endoplasmic reticulum stress-induced apoptosis of retinal ganglion cells in diabetic retinopathy by upregulating and interacting with HSP90AB1

Glucocorticoid activation of anti-inflammatory macrophages protects against insulin resistance

In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathy

Contribution of Müller Cells in the Diabetic Retinopathy Development: Focus on Oxidative Stress and Inflammation

Glucocorticoid Signaling Enhances Expression of Glucose-Sensing Molecules in Immature Pancreatic Beta-Like Cells Derived from Murine Embryonic Stem Cells In Vitro

Diabetic Müller-Glial-Cell-Specific Il6ra Knockout Mice Exhibit Accelerated Retinal Functional Decline and Thinning of the Inner Nuclear Layer

New Insights into the Anti-inflammatory Mechanisms of Glucocorticoids: An Emerging Role for Glucocorticoid-Receptor-Mediated Transactivation

Astrogliosis in the GFAP-CreERT2:Rosa26iDTR Mouse Model Does Not Exacerbate Retinal Microglia Activation or Müller Cell Gliosis under Hypoxic Conditions

Microglia depletion elicits neuroprotective effects to alleviate vascular damage and neuronal cell loss in the diabetic retina

Redox Regulation of Immunometabolism in Microglia Underpinning Diabetic Retinopathy

New Insights into the Mechanisms of Action of Topical Administration of GLP-1 in an Experimental Model of Diabetic Retinopathy